CC
ABBV icon

Centiva Capital’s AbbVie ABBV Stock Holding History

Centiva Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,350
Closed -$994K – 1624
2025
Q4 		$994K Buy
+4,350
New +$991K 0.01% 569
2025
Q3 		– Sell
-1,105
Closed -$205K – 1027
2025
Q2 		$205K Buy
+1,105
New +$205K ﹤0.01% 1330
2025
Q1 		– Sell
-1,097
Closed -$195K – 1487
2024
Q4 		$195K Sell
1,097
-23,864
-96% -$4.39M ﹤0.01% 1373
2024
Q3 		$4.93M Buy
24,961
+12,965
+108% +$2.42M 0.1% 176
2024
Q2 		$2.06M Buy
11,996
+9,979
+495% +$1.65M 0.03% 403
2024
Q1 		$367K Buy
+2,017
New +$348K 0.01% 1146
2023
Q4 		– Sell
-11,776
Closed -$1.72M – 1732
2023
Q3 		$1.76M Buy
+11,776
New +$1.73M 0.04% 427
2022
Q3 		– Sell
-2,924
Closed -$420K – 1443
2022
Q2 		$448K Sell
2,924
-6,302
-68% -$963K 0.01% 961
2022
Q1 		$1.5M Buy
9,226
+4,682
+103% +$680K 0.03% 543
2021
Q4 		$615K Sell
4,544
-36,439
-89% -$4.3M 0.01% 735
2021
Q3 		$4.42M Buy
+40,983
New +$4.68M 0.28% 79
2021
Q2 		– Sell
-7,970
Closed -$862K – 1351
2021
Q1 		$862K Buy
7,970
+2,997
+60% +$321K 0.03% 411
2020
Q4 		$533K Sell
4,973
-10,991
-69% -$1.06M 0.02% 438
2020
Q3 		$1.4M Sell
15,964
-44,483
-74% -$4.19M 0.09% 156
2020
Q2 		$5.93M Buy
60,447
+18,699
+45% +$1.65M 0.36% 37
2020
Q1 		$3.18M Buy
41,748
+38,934
+1,384% +$3.32M 0.14% 101
2019
Q4 		$249K Buy
+2,814
New +$234K 0.01% 607
2019
Q3 		– Sell
-37,974
Closed -$2.6M – 603
2019
Q2 		$2.76M Sell
37,974
-10,102
-21% -$794K 0.16% 115
2019
Q1 		$3.87M Buy
48,076
+42,422
+750% +$3.47M 0.26% 67
2018
Q4 		$521K Buy
5,654
+5,475
+3,059% +$481K 0.04% 180
2018
Q3 		$17K Buy
+179
New +$17K ﹤0.01% 181

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Centiva Capital's ABBV Position: Q1 2026 in Review

Centiva Capital sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 4,350 shares — an estimated $994K sold.

Centiva Capital first reported a position in ABBV in Q3 2018 and held it in 21 quarters. The position peaked at $5.93M in Q2 2020. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Centiva Capital reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Centiva Capital sold 4,350 AbbVie shares in Q1 2026, an estimated $994K.
  • Centiva Capital first reported a position in AbbVie in Q3 2018 and held it in 21 quarters.
  • Centiva Capital's AbbVie position peaked at $5.93M in Q2 2020.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Centiva Capital's 13F filing for Q1 2026, filed 14 May 2026.